This genetic disorder, caused by a mutation of the CF transmembrane conductance regulator (CFTR) gene, is mostly characterized by recurrent lower respiratory infections, exocrine pancreatic insufficiency (85% of patients), and increased electrolyte concentration in sweat. This evidence concerns the gene CFTR and hereditary disease.